Ouster is paying $35 million along with 1.8 million shares.
Abbott Diabetes Care has recalled some of its FreeStyle Libre 3 and FreeStyle Libre 3 Plus glucose monitor sensors for people ...
Researchers have developed a highly sensitive light-based sensor that can detect extremely low concentrations of cancer biomarkers in the blood. The new technology could one day make it possible to ...
News-Medical.Net on MSN
Light-based sensor can detect low concentrations of cancer biomarkers in the blood
Researchers have developed a highly sensitive light-based sensor that can detect extremely low concentrations of cancer ...
In a study led by Assoc. Prof. Dr. Levent Beker from the Department of Mechanical Engineering at Koç University, researchers ...
The FDA has updated some information about the December recall of certain Abbott FreeStyle Libre 3 and 3 Plus glucose sensors ...
Feb 4 (Reuters) - The U.S. Food and Drug Administration on Wednesday classified Abbott's recall of certain glucose monitoring sensors as the most serious after reports tied the devices to seven deaths ...
The SCD52 is a highly stable CO2 sensor designed to address an increasingly relevant challenge in gas sensing: maintaining accuracy long-term without ...
Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results